Y. Bastion et al., INCIDENCE, PREDICTIVE FACTORS, AND OUTCOME OF LYMPHOMA TRANSFORMATIONIN FOLLICULAR LYMPHOMA PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1587-1594
Purpose: To assess the incidence of lymphoma transformation in the nat
ural history of follicular lymphoma (FL) patients and the factors that
are predictive of this event. Patients and Methods: Two hundred twent
y patients with FL treated in our institution between 1975 and 1990, w
ith alpha median follow-up duration of 9 years, were included in this
retrospective analysis. Results: Transformation was proven by histolog
y in 34 patients or by cytology in 13 patients and was considered as h
ighly probable on clinical arguments in five patients for an overall i
ncidence of 24%. The probability of transformation was 22% at 5 years
and 31% at 10 years and tended to plateau after 6 years. Predictive fa
ctors for transformation were nonachievement of complete remission (CR
) after initial therapy (P < 10(-4)), low serum albumin level (< 35 g/
L) (P = .001), and beta(2)-microglobulin level greater than 3 mg/L (P
= .02) at diagnosis. In a multiparametric analysis, only beta(2)-micro
globulin level retained prognostic significance for freedom-from-trans
formation (FFT) survival (P = .04). Transformation accounted for 44% o
f deaths and was associated with a poor outcome, with alpha median sur
vival time of 7 months. Conclusion: Transformation is on early event i
n the course of the disease and is mainly observed in patients with kn
own adverse prognostic factors or those who do not achieve CR after in
itial treatment. These findings may be useful to select follicular lym
phoma patients for intensive therapeutic approaches. (C) 1997 by Ameri
can Society of Clinical Oncology.